BioStock: BioInvent’s CMO comments on the ESMO presentation

BioInvent and Transgene presented promising phase I/IIa data on BT-001 at ESMO in Barcelona this weekend. BioStock contacted BioInvent’s CMO, Andres McAllister, who is attending the conference, to discuss these findings and other recent advancements.

Read the interview with Andres McAllister at biostock.se:

https://www.biostock.se/en/2024/09/bioinvents-cmo-comments-on-the-esmo-presentation/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/